Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma
ClinicalTrials.gov study NCT04121260. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
ClinicalTrials.gov study NCT03110822. IPD Sharing: NO. Countries: 1. Publications: 4.
QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression
ClinicalTrials.gov study NCT00480363. IPD Sharing: Not stated. Countries: 1. Publications: 29.
A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02718833. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04155749. IPD Sharing: NO. Countries: 1. Publications: 2.
Outcome of Multiple Myeloma Associated With Autoimmune Hemolytic Anemia
ClinicalTrials.gov study NCT07354191. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years
ClinicalTrials.gov study NCT03742297. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01562405. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant
ClinicalTrials.gov study NCT06559709. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Trial to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Multiple Myeloma
ClinicalTrials.gov study NCT05478343. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03710915. IPD Sharing: NO. Countries: 1. Publications: 6.
Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year
ClinicalTrials.gov study NCT02348528. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma
ClinicalTrials.gov study NCT00644306. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04635735. IPD Sharing: YES. Countries: 1. Publications: 0.
Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy
ClinicalTrials.gov study NCT02852837. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
ClinicalTrials.gov study NCT03619252. IPD Sharing: NO. Countries: 1. Publications: 6.
Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients
ClinicalTrials.gov study NCT06758375. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01464034. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Non-interventional Study of Lenalidomide / Dexamethasone as First Line Therapy in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02537808. IPD Sharing: NO. Countries: 1. Publications: 0.
A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)
ClinicalTrials.gov study NCT02720510. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.